AcuamarkDx: Tim Gordon, Chiara Gabbi

Acuamark Diagnostics (AcuamarkDx), an early cancer detection company, has added Tim Gordon and Chiara Gabbi to its board of directors.

Gordon has 40 years of experience at Ernst & Young in audit and financial advisory services for both US-based and global health and life sciences companies. He is a graduate of Harvard Business School's Advanced Management Program.

Gabbi is a physician-scientist with more than 20 years of experience in clinical and translational medicine in metabolic diseases, hepatology, cancer, personalized medicine, and genomics. She holds a PhD in medical science from Karolinska Institutet, an MD with specialization in internal medicine from the University of Modena and Reggio Emilia, and a certificate in clinical research from Harvard Medical School.